| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Guaifenesin + theophylline 90mg/150mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guaifenesin 91.44 mg and theophylline 152.4 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guaifenesin + theophylline sodium glycinat 100mg/300mg elixir (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guaifenesin + theophylline, anhydrous 90mg/150mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Potassium iodide + theophylline, anhydrous 130mg/80mg elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Theophylline, anhydrous 100mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guaifenesin 600mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aminophylline 25mg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aminophylline 25mg/mL injection solution 10mL amp |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aminophylline 250mg/10mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Theophylline 300mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Theophylline 50mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Theophylline, anhydrous 600mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing diprophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aminophylline m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aminophylline-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aminophylline 250 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely aminophylline 500 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aminophylline 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aminophylline 105mg/5ml oral liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing diprophylline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Parenteral dyphylline |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dyphylline+guaifenesin 100mg/100mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guaifenesin 100mg/5ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Siltussin sa 100mg/5ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guaifenesin 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guaifenesin 1200mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guaifenesin 200 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guaifenesin 300mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guaifenesin 600mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Theophylline m/r |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Theophylline-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Mebeverine hydrochloride (substance) |
Is a |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing aminophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing theophylline sodium glycinate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Respiratory smooth muscle relaxant (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Smooth muscle relaxant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Brompheniramine maleate + guaifenesin + hydrocodone bitartrate 2mg/200mg/5mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ephedrine hydrochloride + guaifenesin 6.25mg/100mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely ephedrine sulfate 25 milligram and guaifenesin 400 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ephedrine hydrochloride 12.5 mg and guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ephedrine hydrochloride 25 mg and guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing choline theophyllinate and guaifenesin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing ephedrine and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Diprophylline- and guaifenesin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing potassium iodide and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing ephedrine sulfate and hydroxyzine hydrochloride and theophylline |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing guaifenesin and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aminophylline hydrate 350mg modified-release tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aminophylline hydrate 225mg modified-release tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aminophylline hydrate 100mg modified-release tablets |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Vardenafil (substance) |
Is a |
True |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tadalafil (substance) |
Is a |
True |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Montelukast (as montelukast sodium) 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Adverse reaction caused by drug primarily acting on the smooth and skeletal muscles and respiratory system |
Causative agent (attribute) |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Adverse reaction to smooth muscle relaxants |
Causative agent (attribute) |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Adverse reaction to adiphenine |
Causative agent (attribute) |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Adverse reaction to drugs primarily acting on the smooth or skeletal muscles or respiratory system (finding) |
Causative agent (attribute) |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Adverse reaction to smooth muscle relaxant NOS |
Causative agent (attribute) |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing vardenafil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely vardenafil hydrochloride 10 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely vardenafil hydrochloride 5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely vardenafil hydrochloride 20 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cinnamedrine (substance) |
Is a |
True |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Montelukast sodium 4mg oral granules |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Montelukast (as montelukast sodium) 4 mg oral granules sachet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely theophylline 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Theophylline 65mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Theophylline 130mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Theophylline 260mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Xanthine bronchodilators |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dextromethorphan and guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guaifenesin 600mg m/r/dextromethorphan 30mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guaifenesin 1200mg m/r/dextromethorphan 60mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing guaifenesin and hydrocodone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing codeine and guaifenesin and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Theophylline + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing codeine and guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing guaifenesin and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing chlorphenamine and guaifenesin and hydrocodone and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing guaifenesin and phenylephrine and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing guaifenesin and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dextromethorphan and guaifenesin and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing guaifenesin and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Pseudoephedrine + guaifenesin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dexbrompheniramine and guaifenesin and paracetamol and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing choline theophyllinate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| 5-lipoxygenase inhibitor-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Zileuton 600 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing zileuton (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guaifenesin 1200mg m/r/pseudoephedrine 120mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guaifenesin 600mg m/r/pseudoephedrine 60mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dextromethorphan and guaifenesin and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Adiphenine (substance) |
Is a |
True |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing masoprocol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Smooth muscle relaxant allergy |
Causative agent (attribute) |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Avanafil |
Is a |
True |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Drotaverine (substance) |
Is a |
True |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Flavoxate (substance) |
Is a |
True |
Smooth muscle relaxant (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]